Trombetta-eSilva Jessica, Rosset Emilie A, Hepfer R Glenn, Wright Gregory J, Baicu Catalin, Yao Hai, Bradshaw Amy D
Department of Craniofacial Biology, Medical University of South Carolina, Charleston, Clemson, SC, USA.
Department of Bioengineering, Clemson University, Clemson, SC, USA.
J Bone Miner Res. 2015 Oct;30(10):1914-24. doi: 10.1002/jbmr.2522. Epub 2015 May 10.
The periodontal ligament (PDL) is a critical tissue that provides a physical link between the mineralized outer layer of the tooth and the alveolar bone. The PDL is composed primarily of nonmineralized fibrillar collagens. Expression of secreted protein acidic and rich in cysteine (SPARC/osteonectin), a collagen-binding matricellular protein, has been shown to be essential for collagen homeostasis in PDL. In the absence of SPARC, PDL collagen fibers are smaller and less dense than fibers that constitute WT PDL. The aim of this study was to identify cellular mechanisms by which SPARC affected collagen fiber assembly and morphology in PDL. Cross-linking of fibrillar collagens is one parameter that is known to affect insoluble collagen incorporation and fiber morphology. Herein, the reduction in collagen fiber size and quantity in the absence of SPARC expression was shown to result in a PDL with reduced molar extraction force in comparison to that of WT mice (C57Bl/6J). Furthermore, an increase in transglutaminase activity was found in SPARC-null PDL by biochemical analyses that was supported by immunohistochemical results. Specifically, collagen I was identified as a substrate for transglutaminase in PDL and transglutaminase activity on collagen I was found to be greater in SPARC-null tissues in comparison to WT. Strikingly, inhibition of transglutaminase activity in SPARC-null PDL resulted in increases in both collagen fiber thickness and in collagen content, whereas transglutaminase inhibitors injected into WT mice resulted in increases in collagen fiber thickness only. Furthermore, PDL treated with transglutaminase inhibitors exhibited increases in molar extraction force in WT and in SPARC-null mice. Thus, SPARC is proposed to act as a critical regulator of transglutaminase activity on collagen I with implications for mechanical strength of tissues.
牙周韧带(PDL)是一种关键组织,它在牙齿的矿化外层与牙槽骨之间提供物理连接。PDL主要由非矿化的纤维状胶原蛋白组成。分泌性富含半胱氨酸的酸性蛋白(SPARC/骨连接素)是一种胶原结合基质细胞蛋白,其表达已被证明对PDL中的胶原稳态至关重要。在缺乏SPARC的情况下,PDL胶原纤维比构成野生型(WT)PDL的纤维更小且密度更低。本研究的目的是确定SPARC影响PDL中胶原纤维组装和形态的细胞机制。纤维状胶原蛋白的交联是一个已知会影响不溶性胶原掺入和纤维形态的参数。在此,与WT小鼠(C57Bl/6J)相比,在缺乏SPARC表达的情况下胶原纤维尺寸和数量的减少导致PDL的磨牙拔除力降低。此外,通过生化分析在SPARC基因敲除的PDL中发现转谷氨酰胺酶活性增加,免疫组化结果也支持这一点。具体而言,I型胶原被确定为PDL中转谷氨酰胺酶的底物,并且与WT相比,在SPARC基因敲除组织中I型胶原上的转谷氨酰胺酶活性更高。引人注目的是,抑制SPARC基因敲除的PDL中的转谷氨酰胺酶活性会导致胶原纤维厚度和胶原含量均增加,而注射到WT小鼠体内的转谷氨酰胺酶抑制剂仅导致胶原纤维厚度增加。此外,用转谷氨酰胺酶抑制剂处理的PDL在WT和SPARC基因敲除小鼠中均表现出磨牙拔除力增加。因此,有人提出SPARC作为I型胶原上转谷氨酰胺酶活性的关键调节因子,对组织的机械强度有影响。